The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients
Background. Prevention of alloreactivity by rabbit anti-thymocyte globulins (rATG) may not only result from immunodepletion but also from the induction of T cells that control allogeneic immune responses. In the present prospective and controlled study, we investigated the effect of rATG on the frequency, function and phenotype of peripheral immunoregulatory CD4+ T cells in kidney transplant (KTx) patients.Methods. After transplantation, 16 patients received ATG-induction therapy and triple therapy consisting of tacrolimus, MMF and steroids. The control group (n = 18) received triple therapy only. By flow cytometry, T cells were analysed for CD25, FoxP3, CD127, CD45RO and CCR7. To study their suppressive capacities, CD25bright T cells were co-cultured with CD25-dim effector T cells (Teff) in mixed lymphocyte reactions (MLR), stimulated with donor and third party (3P) antigens.Results. Pre-transplant levels of FoxP3+CD127-low T cells were 6 of CD4+ T cells. One week post-ATG treatment, no measurable numbers of regulatory T cells were present (P < 0.01). After 4 weeks, the cell numbers of CD4+FoxP3+CD127-low T cells slowly reappeared and thereafter remained low (P < 0.01). At 14 weeks, a significant shift towards the CD45RO+CCR7+ (central memory) phenotype within CD4+FoxP3+ T cells was observed (P < 0.01). At 26 weeks, the proliferative alloresponses of the PBMC and CD25-dim Teff profoundly decreased compared to pre-transplant (P = 0.01 and P = 0.02 respectively), while the regulatory capacity of the CD25bright T cells, of which 90 consisted of FoxP3+CD127-low T cells, remained unaffected. The CD25bright T cells suppressed the anti-donor (94) and 3P responses (93).Conclusion. Our findings show that rATG therapy does not spare peripheral immunoregulatory T cells in vivo, but after regeneration preserves their suppressive activity.
|Keywords||CD4+ T lymphocyte, CD45RO antigen, Kidney transplantation, Memory T cells, Patients, Rabbit ATG induction therapy, Regulatory T cells, T lymphocyte, adult, aged, alloimmunity, article, chemokine receptor CCR7, clinical article, clinical trial, coculture, controlled clinical trial, controlled study, drug effect, effector t cell, female, flow cytometry, human, human cell, interleukin 2 receptor alpha, interleukin 7 receptor, kidney graft rejection, kidney transplantation, lymphocyte count, male, mixed lymphocyte reaction, mycophenolic acid 2 morpholinoethyl ester, peripheral blood mononuclear cell, phenotype, prednisone, priority journal, prospective study, regulatory T lymphocyte, tacrolimus, thymocyte antibody, transcription factor FOXP3|
|Persistent URL||dx.doi.org/10.1093/ndt/gfn778, hdl.handle.net/1765/16395|
Sewgobind, V.D.K.D., Kho, M.M.L., van der Laan, L.J.W., Hendrikx, T.K., van Dam, T., Tilanus, H.W., … Baan, C.C.. (2009). The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients. Nephrology, Dialysis, Transplantation, 24(5), 1635–1644. doi:10.1093/ndt/gfn778